Snyder Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UGI
UGI
|
+$20.2M |
| 2 |
Ligand Pharmaceuticals
LGND
|
+$15.6M |
| 3 |
PDCE
PDC Energy, Inc.
PDCE
|
+$9.29M |
| 4 |
Y
Alleghany Corp
Y
|
+$8.02M |
| 5 |
OPLN
Openlane
OPLN
|
+$4.92M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Entegris
ENTG
|
+$23.3M |
| 2 |
SRCI
SRC Energy Inc
SRCI
|
+$16.7M |
| 3 |
HEICO Corp Class A
HEI.A
|
+$13.5M |
| 4 |
LTHM
Livent Corporation
LTHM
|
+$13.3M |
| 5 |
Teledyne Technologies
TDY
|
+$11.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 29.12% |
| 2 | Technology | 20.64% |
| 3 | Healthcare | 13.48% |
| 4 | Financials | 9.17% |
| 5 | Consumer Staples | 8.18% |
Similar funds
Snyder Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Snyder Capital Management held 76 positions worth $1.76B, down 31% from $2.54B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Snyder Capital Management withdrew a net $111M in Q1 2020, closing 1 position and reducing 44 holdings. Its most notable exit was SRC Energy Inc, an estimated $16.7M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 29% of assets, down from 30% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Snyder Capital Management opened a new position in Ligand Pharmaceuticals worth $12.5M.
- Snyder Capital Management's largest Q1 2020 buy was Ligand Pharmaceuticals: 274,618 shares worth $12.5M.
- Snyder Capital Management added most to UGI in Q1 2020, an estimated $20.2M increase.
- Snyder Capital Management's biggest Q1 2020 reduction was Entegris, cutting an estimated $23.3M.
- Snyder Capital Management fully exited SRC Energy Inc in Q1 2020, selling an estimated $16.7M.
- Snyder Capital Management's ten largest holdings make up 35% of its $1.76B portfolio in Q1 2020.
- Snyder Capital Management opened 5 new positions and closed 1 in Q1 2020.
- Snyder Capital Management's portfolio value fell 31% quarter-over-quarter to $1.76B.
Based on Snyder Capital Management's 13F filing for Q1 2020, filed 15 May 2020.